A rotator cuff balloon (10) is disclosed, the rotator cuff balloon (10) includes a limiting structure (100) and a protective structure (200) connected to the limiting structure (100). The limiting structure (100) defines a curvature along a coronal plane. The rotator cuff balloon (10) conforms to the physiological structure of the human shoulder joint limits itself in the subacromial space and can reduce a patient's foreign body sensation, dislocation, functional failure and other adverse events.

An intervertebral implant component of an intervertebral implant includes an outer surface for engaging an adjacent vertebra and an inner surface. A keel extends from the outer surface and is designed to be disposed in a slot provided in the adjacent vertebra. This keel extends in a plane which is non-perpendicular to the outer surface; and preferably there are two of the keels extending from the outer surface which are preferably offset laterally from one another. In another embodiment, an anterior shelf is provided at an anterior end of the outer surface, and this anterior shelf extends vertically away from the inner surface in order to help prevent bone growth from the adjacent vertebra towards the inner surface. Further in accordance with disclosed embodiments, various materials, shapes and forms of construction of the component and/or keel provide various benefits.

A system of prosthetic implants for a total knee replacement procedure is provided. The system includes a tibial component of a knee joint implant, a tibial insert configured to be positioned against the superior side of the platform of the tibial component, a first femoral component of a knee joint implant, and a second femoral component of a knee joint implant.

A disposable device for treating a condition of a ureter or kidney having a cylindrical body about 1-2 mm in diameter by about 5 to 10 mm in length and having a top and bottom end. The body is made of absorbent material that expands upon contact with pharmaceutical agent and bodily fluids and includes a string connected to the bottom end of the body for removing the device. The device can be used to treat a condition of the ureter or kidney by inserting into the ureter or kidney, delivering a pharmaceutical agent, and removing the device after it has been impregnated with fluid. The device can be included in a kit with an insertion device and/or appropriate pharmaceutical agents.

A rotator cuff balloon (10) includes a limiting structure (100) and a protective structure (200) connected to the limiting structure (100). The limiting structure (100) has a curvature along a coronal plane (102). This rotator cuff balloon (10) conforms to the physiological structure of the shoulder joint in the human body, limits itself in the subacromial space and can reduce a patient's foreign body sensation, dislocation, functional failure and other adverse events. The protective structure (200) is configured to be supported in the space between the humeral head and the acromion of the shoulder joint in the human body to provide support. Moreover, the humeral head of a patient with a rotator cuff injury is raised, avoiding pain arising from inter-tissue collisions, increasing the moment arm of the deltoid muscle and resulting in immediate improvements in the functions of the patient's shoulder joint. The limiting structure (100) is configured to fit against at least part of the humeral head of the shoulder joint in the human body, thus providing a position-limiting effect and avoiding displacement of the prosthesis.

The disclosure provides a tubular stent comprising at least three primary elongate columns disposed around a circumference of the stent. The primary elongate columns substantially parallel to a longitudinal axis of the stent. The stent further comprises at least two non-linear struts disposed between each pair of circumferentially adjacent primary columns, wherein each strut extends between the circumferentially adjacent primary columns. The stent is configured to adopt a first, unexpanded configuration and a second, expanded configuration in which the stent has a greater diameter than in the first, unexpanded configuration.

Assemblies of one or more implant structures make possible the achievement of diverse interventions involving the fusion and/or stabilization of the SI-joint and/or lumbar and sacral vertebra in a non-invasive manner, with minimal incision, and without the necessitating the removing the intervertebral disc. The representative lumbar spine interventions, which can be performed on adults or children, include, but are not limited to, SI-joint fusion or fixation; lumbar interbody fusion; translaminar lumbar fusion; lumbar facet fusion; trans-iliac lumbar fusion; and the stabilization of a spondylolisthesis.

In various embodiments, an implant for interfacing with a bone structure includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue. In some embodiments, a method is provided that includes accessing an intersomatic space and inserting an implant into the intersomatic space. The implant includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue.

In various embodiments, an implant for interfacing with a bone structure includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue. In some embodiments, a method is provided that includes accessing an intersomatic space and inserting an implant into the intersomatic space. The implant includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue.

A biodegradable stent that is degraded in a living body includes a stent body that is made of a biodegradable material and is deformed to have an expanded diameter in the living body; and a biodegradable drug-coating portion formed on the stent body. The drug-coating portion is degraded, in an expansion retention period during which an expansion retention force (radial force) of the deformed diameter-expanded stent body that acts on an inner wall of a lumen thereof is maintained, and before 60% of a degradation period from indwelling of the stent body in the living body to complete degradation thereof elapses.